Gentian Diagnostics Dividends and Buybacks
Dividend criteria checks 0/6
Gentian Diagnostics is a dividend paying company with a current yield of 1.59%. Next payment date is on 18th May, 2026 with an ex-dividend date of 6th May, 2026.
Key information
1.6%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 2.7% |
| Dividend Growth | n/a |
| Next dividend pay date | 18 May 26 |
| Ex dividend date | 06 May 26 |
| Dividend per share | n/a |
| Payout ratio | 70% |
Recent dividend and buyback updates
Recent updates
Gentian Diagnostics ASA Just Missed Earnings - But Analysts Have Updated Their Models
Feb 14
Gentian Diagnostics ASA's (OB:GENT) 34% Cheaper Price Remains In Tune With Earnings
Feb 13With A 34% Price Drop For Gentian Diagnostics ASA (OB:GENT) You'll Still Get What You Pay For
Feb 13Gentian Diagnostics' (OB:GENT) Performance Raises Some Questions
Oct 31Market Participants Recognise Gentian Diagnostics ASA's (OB:GENT) Revenues Pushing Shares 27% Higher
May 09Why Gentian Diagnostics' (OB:GENT) Earnings Are Weaker Than They Seem
Feb 20
Launching NT-proBNP Test And Expanding Partnerships Will Broaden Cardiology Portfolio
Strategic partnerships and continual global expansion enhance Gentian's market presence and drive revenue growth.Gentian Diagnostics ASA's (OB:GENT) P/S Is Still On The Mark Following 25% Share Price Bounce
Feb 07Investors Appear Satisfied With Gentian Diagnostics ASA's (OB:GENT) Prospects As Shares Rocket 33%
Jun 29Analyst Estimates: Here's What Brokers Think Of Gentian Diagnostics ASA (OB:GENT) After Its Annual Report
Feb 14Here's Why We're Not At All Concerned With Gentian Diagnostics' (OB:GENT) Cash Burn Situation
Oct 28We're Not Worried About Gentian Diagnostics' (OB:GENT) Cash Burn
May 11Can You Imagine How Gentian Diagnostics' (OB:GENT) Shareholders Feel About The 57% Share Price Increase?
Mar 20What Percentage Of Gentian Diagnostics AS (OB:GENT) Shares Do Insiders Own?
Feb 21Have Insiders Been Selling Gentian Diagnostics AS (OB:GENT) Shares?
Jan 17
Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: GENT is not paying a notable dividend for the Norwegian market, therefore no need to check if payments are stable.
Growing Dividend: GENT is not paying a notable dividend for the Norwegian market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Gentian Diagnostics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (GENT) | 1.6% |
| Market Bottom 25% (NO) | 3.3% |
| Market Top 25% (NO) | 7.6% |
| Industry Average (Medical Equipment) | 2.1% |
| Analyst forecast (GENT) (up to 3 years) | 2.7% |
Notable Dividend: GENT's dividend (1.59%) isn’t notable compared to the bottom 25% of dividend payers in the Norwegian market (3.16%).
High Dividend: GENT's dividend (1.59%) is low compared to the top 25% of dividend payers in the Norwegian market (7.53%).
Earnings Payout to Shareholders
Earnings Coverage: GENT is not paying a notable dividend for the Norwegian market.
Cash Payout to Shareholders
Cash Flow Coverage: GENT is not paying a notable dividend for the Norwegian market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/09 10:15 |
| End of Day Share Price | 2026/03/09 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Gentian Diagnostics ASA is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Martinsson | DNB Carnegie |
| Geir Holom | DNB Carnegie |